Search results for the GEO ID: GSE38224
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM936970
GPL1261
Ring1A/B cKO mock (OHT-) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing an empty vector (OHT-untreated: Ring1A(-/-)) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: an empty vector treatment: OHT-untreated: Ring1A(-/-) cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing an empty vector (OHT-untreated: Ring1A(-/-))
GSM936971
GPL1261
Ring1A/B cKO mock (OHT+) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing an empty vector (2 days after the start of OHT treatment: Ring1A/B-dKO) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: an empty vector treatment: OHT treatment: Ring1A/B-dKO cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing an empty vector (2 days after the start of OHT treatment: Ring1A/B-dKO)
GSM936972
GPL1261
Ring1A/B cKO expressing WT Ring1B #1 (OHT-) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing WT Ring1B construct #1 (OHT-untreated) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: WT Ring1B construct #1 treatment: OHT-untreated cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing WT Ring1B construct #1 (OHT-untreated)
GSM936973
GPL1261
Ring1A/B cKO expressing WT Ring1B #1 (OHT+) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing WT Ring1B construct #1 (2 days after the start of OHT treatment) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: WT Ring1B construct #1 treatment: OHT treatment cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing WT Ring1B construct #1 (2 days after the start of OHT treatment)
GSM936974
GPL1261
Ring1A/B cKO expressing WT Ring1B #3 (OHT-) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing WT Ring1B construct #3 (OHT-untreated) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: WT Ring1B construct #3 treatment: OHT-untreated cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing WT Ring1B construct #3 (OHT-untreated)
GSM936975
GPL1261
Ring1A/B cKO expressing WT Ring1B #3 (OHT+) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing WT Ring1B construct #3 (2 days after the start of OHT treatment) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: WT Ring1B construct #3 treatment: OHT treatment cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing WT Ring1B construct #3 (2 days after the start of OHT treatment)
GSM936976
GPL1261
Ring1A/B cKO expressing I53S Ring1B #1 (OHT-) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53S Ring1B construct #1 (OHT-untreated) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: I53S Ring1B construct #1 treatment: OHT-untreated cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53S Ring1B construct #1 (OHT-untreated)
GSM936977
GPL1261
Ring1A/B cKO expressing I53S Ring1B #1 (OHT+) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53S Ring1B construct #1 (2 days after the start of OHT treatment) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: I53S Ring1B construct #1 treatment: OHT treatment cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53S Ring1B construct #1 (2 days after the start of OHT treatment)
GSM936978
GPL1261
Ring1A/B cKO expressing I53S Ring1B #4 (OHT-) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53S Ring1B construct #4 (OHT-untreated) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: I53S Ring1B construct #4 treatment: OHT-untreated cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53S Ring1B construct #4 (OHT-untreated)
GSM936979
GPL1261
Ring1A/B cKO expressing I53S Ring1B #4 (OHT+) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53S Ring1B construct #4 (2 days after the start of OHT treatment) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: I53S Ring1B construct #4 treatment: OHT treatment cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53S Ring1B construct #4 (2 days after the start of OHT treatment)
GSM936980
GPL1261
Ring1A/B cKO expressing I53A Ring1B #1 (OHT-) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53A Ring1B construct #1 (OHT-untreated) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: I53A Ring1B construct #1 treatment: OHT-untreated cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53A Ring1B construct #1 (OHT-untreated)
GSM936981
GPL1261
Ring1A/B cKO expressing I53A Ring1B #1 (OHT+) Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53A Ring1B construct #1 (2 days after the start of OHT treatment) genotype/variation: Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 expression: I53A Ring1B construct #1 treatment: OHT treatment cell type: Embryonic stem cells background mouse strain: 129/B6 hybrid Ring1A(-/-);Ring1B(fl/fl);Rosa26::CreERT2 ES cells expressing I53A Ring1B construct #1 (2 days after the start of OHT treatment)
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes